In an action challenging the Food and Drug Administration’s approval of an anthrax vaccine and seeking to enjoin the Defense Department from administering it to military personnel, dismissal of the complaint is affirmed where: 1) the court deferred to the FDA’s judgment that the vaccine was effective regardless of the route of exposure; and 2) the FDA did not act arbitrarily or capriciously in resting a finding of effectiveness on the results of a challenged study.
Read Rempfer v. Sharfstein, No. 08-5117
Appellate Information
Argued April 20, 2009
Decided September 29, 2009
Counsel
For Appellants:
John J. Michels Jr. and Mark S. Zaid, Baker & McKenzie LLP, Chicago, IL
For Appellees:
Melissa N. Patterson, Michael F. Hertz, Jeffrey A. Taylor and Mark B. Stern, U.S. Department of Justice, Washington, DC
You Don’t Have To Solve This on Your Own – Get a Lawyer’s Help
Civil Rights
Block on Trump’s Asylum Ban Upheld by Supreme Court
Criminal
Judges Can Release Secret Grand Jury Records
Politicians Can’t Block Voters on Facebook, Court Rules
